Zobrazeno 1 - 10
of 11
pro vyhledávání: '"N. Emmanuel Díaz-Martínez"'
Autor:
Valeria Valadez-Barba, A. Cota-Coronado, O.R. Hernández-Pérez, Pavel H. Lugo-Fabres, Eduardo Padilla-Camberos, Néstor Fabián Díaz, N. Emmanuel Díaz-Martínez
Publikováno v:
Regenerative Therapy, Vol 15, Iss , Pp 332-339 (2020)
Neurodegenerative disorders such as Parkinson's and Alzheimer's disease, are fundamental health concerns all around the world. The development of novel treatments and new techniques to address these disorders, are being actively studied by researcher
Externí odkaz:
https://doaj.org/article/beec683f204c4c57b3ba63fdd4f636e9
Autor:
Karen J. Juárez-Navarro, Eduardo Padilla-Camberos, Néstor Fabián Díaz, Ariel Miranda-Altamirano, N. Emmanuel Díaz-Martínez
Publikováno v:
Stem Cells International, Vol 2020 (2020)
Mesenchymal stem cells (MSCs), defined as plastic adherent cells with multipotent differentiation capacity in vitro, are an emerging and valuable tool to treat a plethora of diseases due to their therapeutic mechanisms such as their paracrine activit
Externí odkaz:
https://doaj.org/article/4540d1d29f894eb7883605f6610d233e
Autor:
Agustin Cota-Coronado, Néstor Fabián Díaz-Martínez, Eduardo Padilla-Camberos, N. Emmanuel Díaz-Martínez
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 12 (2019)
The translational gap to treatments based on gene therapy has been reduced in recent years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and its variations. This has allowed the development of more precise therapies fo
Externí odkaz:
https://doaj.org/article/20ae13a3662c433e922648ce097475f7
Autor:
Agustín Cota-Coronado, Jennifer C. Durnall, Néstor Fabián Díaz, Lachlan H. Thompson, N. Emmanuel Díaz-Martínez
Publikováno v:
Molecules, Vol 25, Iss 5, p 1150 (2020)
Human induced pluripotent stem cells (hiPSCs) have transformed conventional drug discovery pathways in recent years. In particular, recent advances in hiPSC biology, including organoid technologies, have highlighted a new potential for neural drug di
Externí odkaz:
https://doaj.org/article/440326aa950341a0adf1996102759718
Autor:
A. Cota-Coronado, O.R. Hernández-Pérez, Néstor F. Díaz, Pavel H. Lugo-Fabres, N. Emmanuel Díaz-Martínez, Valeria Valadez-Barba, Eduardo Padilla-Camberos
Publikováno v:
Regenerative Therapy, Vol 15, Iss, Pp 332-339 (2020)
Regenerative Therapy
Regenerative Therapy
Neurodegenerative disorders such as Parkinson's and Alzheimer's disease, are fundamental health concerns all around the world. The development of novel treatments and new techniques to address these disorders, are being actively studied by researcher
Autor:
N. Emmanuel Díaz-Martínez, Ariel Miranda-Altamirano, Eduardo Padilla-Camberos, Néstor F. Díaz, Karen J Juárez-Navarro
Publikováno v:
Stem Cells International
Stem Cells International, Vol 2020 (2020)
Stem Cells International, Vol 2020 (2020)
Mesenchymal stem cells (MSCs), defined as plastic adherent cells with multipotent differentiation capacity in vitro, are an emerging and valuable tool to treat a plethora of diseases due to their therapeutic mechanisms such as their paracrine activit
Autor:
Lachlan H. Thompson, Agustin Cota-Coronado, Néstor F. Díaz, N. Emmanuel Díaz-Martínez, Jennifer C. Durnall
Publikováno v:
Molecules
Molecules, Vol 25, Iss 5, p 1150 (2020)
Molecules, Vol 25, Iss 5, p 1150 (2020)
Human induced pluripotent stem cells (hiPSCs) have transformed conventional drug discovery pathways in recent years. In particular, recent advances in hiPSC biology, including organoid technologies, have highlighted a new potential for neural drug di
Publikováno v:
Neural Regeneration Research
Neural Regeneration Research, Vol 15, Iss 2, Pp 255-256 (2020)
Neural Regeneration Research, Vol 15, Iss 2, Pp 255-256 (2020)
Autor:
Néstor Fabián Díaz-Martínez, N. Emmanuel Díaz-Martínez, Agustin Cota-Coronado, Eduardo Padilla-Camberos
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 12 (2019)
Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience
The translational gap to treatments based on gene therapy has been reduced in recent years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and its variations. This has allowed the development of more precise therapies fo
Autor:
Iván Velasco, N Fabián Díaz, Alfredo Varela-Echavarría, Claudia M. García-Peña, Elisa Tamariz, N. Emmanuel Díaz-Martínez
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 21(8)
Cell therapy in animal models of Parkinson's disease (PD) is effective after intrastriatal grafting of dopamine (DA) neurons, whereas intranigral transplantation of dopaminergic cells does not cause consistent behavioral recovery. One strategy to pro